This study demonstrates that deleting TβRII in the PT worsens mitochondrial injury, partly by disrupting mitochondrial quality control, leads to a metabolic switch toward aerobic glycolysis (Warburg-like effect) and exacerbates Th1 inflammatory response in CKD. Here, TGFBR2 is linked to chronic kidney disease.